WebJan 25, 2024 · Orrick Herrington & Sutcliffe is expanding its life sciences group with the addition of David Schulman, who co-led the same practice area for Dechert. Schulman has advised Celgene Corp., Ferring Pharmaceuticals SA, Adocia SAS and Pfizer Inc., among others, on transactions. He recently took the lead on BioAtla Inc.’s $72 million series D ... WebJan 25, 2024 · David Schulman began at Dechert more than 30 years ago. He was the former co-head of Dechert’s life sciences group. Orrick Herrington & Sutcliffe is …

David Schulman - Principal Shareholder - Greenberg Traurig, LLP

WebDavid Schulman is a trusted advisor to life sciences companies on complex global transactions. He provides strategic guidance on transactions involving mergers, … David Schulman - Mercati finanziari, Fusioni e acquisizioni, Gruppo società nel … David Schulman is a trusted advisor to life sciences companies on complex global … David Schulman is a trusted advisor to life sciences companies on complex global … Public Companies and Corporate Governance. We act as outside … WebDavid Schulman Atlanta, Georgia, United States 3K followers 500+ connections Join to view profile Greenberg Traurig, LLP Experience Principal Shareholder Greenberg … medtech ceo conference

Orrick, Herrington & Sutcliffe LLP, USA 2024 Chambers Profiles

WebJul 1, 2024 · O'Donnell has advised emerging life sciences companies in more than 300 venture capital financings totaling $7 billion, according to Orrick. He assisted Auris … WebClients include more than 3,700 tech and life sciences companies, 6 of the 10 largest public tech companies, 300+ VC investors and 80+ unicorns. Orrick partners with clients on virtually every transaction type – formation through going public – and achieves outstanding litigation and regulatory outcomes for them. WebDavid Schulman Account Executive at Shapco Printing - Real Estate Investor Minneapolis, Minnesota, United States 5K followers 500+ … med tech certification in california